Skip to main content
McMaster University Menu Search

Platforms

Drug Discovery-icon

Drug Discovery

Drug screening is a powerful method for identifying new therapeutics for diseases. Our approach is to adapt human cells to a screening format so that we can find targeted therapeutics to combat cancer, neural disorders and metabolic disorders.

Principal Investigators

Mick Bhatia

Mick Bhatia

Director and Senior Scientist

Brad Doble

Brad Doble

Principal Investigator

Jon Draper

Jon Draper

Principal Investigator

Yu Lu

Yu Lu

Principal Investigator

Karun Singh

Karun Singh

Principal Investigator

Sheila Singh

Sheila Singh

Principal Investigator

Eva Szabo

Eva Szabo

Principal Investigator

Related Projects

The ability to screen for drugs that can target the root causes of neural disorders, including pain and dysfunction in autism spectrum disorder.

Demonstrating the ability of the Wnt pathway to suppress tumour progression in childhood medulloblastoma, thus establishing activated Wnt signaling as a novel treatment paradigm.

The development of new in vitro human-specific lung cancer models.

Related News

SCCRI uncovers unexpected cells responsible for leukemia relapse, offering new leads for therapy

SCCRI uncovers unexpected cells responsible for leukemia relapse, offering new leads for therapy

The Bhatia Lab has characterised the process of how leukemia cells initially respond to treatment but retaliate after chemotherapy. Findings help predict the risk of disease recurrence and can be therapeutically used to prevent relapse. [...]

Lili Aslostovar

Lili Aslostovar | Wednesday, September 12, 2018

SCC-RI scientist unravels genetic mystery causing complex brain disorders, including autism

SCC-RI scientist unravels genetic mystery causing complex brain disorders, including autism

Dr. Karun Singh and his team pinpoint key genes causing brain development disorders [...]

Karun Singh

Karun Singh | Monday, March 5, 2018

Spoiling the soil for leukemia favours normal blood cells

Spoiling the soil for leukemia favours normal blood cells

Promoting fat cells in the bone marrow inhibits leukemic cells but promotes normal blood generation [...]

Tony Collins

Tony Collins | Monday, October 16, 2017